Fairfield Financial Advisors’s AbbVie ABBV Stock Holding History

Fairfield Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-873	Closed	-$155K	–	67
2024 Q4	$155K	Buy	873 +3	+0.3%	+$552	0.05%	75
2024 Q3	$172K	Buy	870 +3	+0.3%	+$560	0.06%	78
2024 Q2	$149K	Buy	+867	New	+$144K	0.04%	79
2023 Q4	$171K	Buy	1,102 +603	+121%	+$87.9K	0.07%	79
2023 Q3	$74.3K	Sell	499 -146	-23%	-$21.4K	0.03%	110
2023 Q2	$86.9K	Buy	645 +5	+0.8%	+$733	0.03%	107
2023 Q1	$101K	Buy	640 +4	+0.6%	+$612	0.04%	95
2022 Q4	$103K	Sell	636 -102	-14%	-$15.6K	0.05%	90
2022 Q3	$99.1K	Sell	738 -100	-12%	-$14.3K	0.05%	89
2022 Q2	$128K	Buy	838 +5	+0.6%	+$764	0.06%	78
2022 Q1	$135K	Buy	+833	New	+$121K	0.05%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fairfield Financial Advisors's ABBV Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 873 shares — an estimated $155K sold.

Fairfield Financial Advisors first reported a position in ABBV in Q1 2022 and held it in 11 quarters. The position peaked at $172K in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Fairfield Financial Advisors reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Fairfield Financial Advisors sold 873 AbbVie shares in Q1 2025, an estimated $155K.
Fairfield Financial Advisors first reported a position in AbbVie in Q1 2022 and held it in 11 quarters.
Fairfield Financial Advisors's AbbVie position peaked at $172K in Q3 2024.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.